US2022362284A1PendingUtilityA1
Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
Assignee: PARADIGM HEALTH SCIENCES PTY LTDPriority: Feb 2, 2011Filed: Jul 5, 2022Published: Nov 17, 2022
Est. expiryFeb 2, 2031(~4.5 yrs left)· nominal 20-yr term from priority
Inventors:Peter Ghosh
A61P 19/00A61K 31/737A61K 9/0019A61K 31/727A61P 7/10A61P 19/08
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for the treatment of bone marrow edema in a mammal comprising administering an effective amount of a polysulfated polysaccharide including salts thereof, to a mammal in need of such treatment.
Claims
exact text as granted — not AI-modified1 - 12 . (canceled)
13 . A method for the treatment of bone marrow edema in the joint of a mammal presumed to be also suffering from osteoarthritis in the joint comprising administering to the mammal from about 1 mg/kg to about 2 mg/kg of the mammal per dose of a sodium salt of pentosan polysulfate, the method including as necessary diagnostically confirming the presence of osteoarthritis in the joint.
14 . The method claim 1 wherein treatment is by administering an injection by the intra-muscular (IM) or subcutaneous (SC) routes, intra-venously (IV), intra-articularly (IA), peri-articularly, topically, via suppositories or orally.
15 . The method according to claim 2 wherein the treatment is by administering an injection intra-muscularly or subcutaneously.
16 . The method, according to claim 3 wherein administration to a human is by dosing in a treatment regimen once daily, twice weekly or thrice weekly.
17 . The method according to claim 4 wherein the total dose of polysulfated polysaccharide administered in the treatment regimen is about 200-2000 mg.Join the waitlist — get patent alerts
Track US2022362284A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.